NRC Health vs OptimizeRx
NRC Health reported revenue of $137 million in fiscal 2025, 1.3 times OptimizeRx's $109 million in fiscal 2025. NRC Health's revenue fell 4.0% in its latest year, and OptimizeRx's grew 18.8%. NRC Health had an operating margin of 16.4%, against 10.7% at OptimizeRx. Free cash flow was $16 million at NRC Health and $19 million at OptimizeRx.
Side by side
| NRC Health | OptimizeRx | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $137M | $109M |
| Revenue growth | −4.0% | 18.8% |
| Revenue growth a year, last 5 years | 0.6% | 20.4% |
| Gross margin | — | 67.2% |
| Operating margin | 16.4% | 10.7% |
| Net margin | 8.4% | 4.7% |
| Free cash flow | $16M | $19M |
| Free cash flow margin | 11.5% | 17.1% |
| Return on capital | 16.4% | 6.4% |
| Net debt to EBITDA | 2.5x | 0.2x |
| Dividends and buybacks | $31M | $0M |
| Change in diluted share count | −5.7% | 3.9% |
| Last close | $24.99 | $7.01 |
| P/E at the last close | — | 28.0× |
| Insider trades, last 12 months | bought $98,160, sold $0 | sold $18,752 |
| Piotroski F-score | 5 of 8 | 8 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
NRC HealthOptimizeRx
Operating margin
Percent of revenue
NRC HealthOptimizeRx
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
NRC HealthOptimizeRx
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the NRC Health and OptimizeRx pages.